Editor Rebekah Jordan spoke to Honeywell to explore its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients.
Editor Rebekah Jordan spoke to Kevin Kreutter, Ph.D., senior vice president, Drug Discovery, Empress Therapeutics about how the company is using AI to analyse genetic data, to accelerate and refine small molecule drug discovery.
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design.
Editor Rebekah Jordan speaks to Ivan Wall, a professor at the University of Birmingham and co-director of the Resilience project, to learn about the advancements the initiative is making in UK medicines manufacturing.
Broughton highlights the top three tips in choosing a stability partner and explains how its extensive expertise positions it as a leader in stability testing.
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing.
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner.
Nataliya Andreychuk, CEO and co-founder of Viseven, explores how to leverage content in pharma beyond traditional marketing goals, highlighting customer education, societal influence, product development and policy impact.
Philipp Markolin, scientific marketing manager at peptide and oligonucleotide manufacturers Bachem, shares his insights on the latest innovations in sustainable oligonucleotide manufacturing to boost efficiency and reduce waste.
Beth Tran, global business manager, CR Excipients, Colorcon, explains how innovations in controlled release systems, film coatings and functional excipients are driving the future of drug delivery.
James Bury, director technology at Tjoapack, examines the increasing need for innovative solutions in pharmaceutical packaging, emphasising novel approaches and emerging technologies that address changing packaging requirements.
